Today

Agents

Chat

Arena

Discover

More

App

Sunshine Biopharma wins Canadian approval for generic Enalapril tablets - SBFM News | Rallies

Sunshine Biopharma wins Canadian approval for generic Enalapril tablets

SBFM•2026-08-19

Canadian approval and launch plans

Sunshine Biopharma won Canadian regulatory clearance for generic Enalapril tablets, expanding its cardiovascular portfolio.

Shipments to Canadian pharmacies are targeted by end-2026 via subsidiary Nora Pharma’s distribution network.

The move positions the company for demand in the global anti-hypertensive market, valued at USD 25.94 billion in 2025.

Related News

Nasdaq trade halt TNON.O volatility trading pause at 10:11 AM

TNON•2026-08-19

NOAA publishes TMC USA deep-sea mining permit application in Federal Register

TMC•2026-08-19

Nasdaq trade halt continues UCFI.O reason not available at 09:45 AM

Sources

D

Sunshine Biopharma wins Canadian approval for generic Enalapril tablets

Docs

2026-08-19

Nasdaq trade halt RDAC.O volatility trading pause at 09:32 AM

RDAC•2026-08-19

Nasdaq trade halt continues <UCFI.O> reason not available at 09:58 AM

UCFI•2026-08-19